PMVP - PMV Pharmaceuticals, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 2.04

Open

$ 2.15

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.98 - $ 2.16

52 Week Range

$ 1.18 - $ 9.72

Volume

311,504

Average Volume

Market Cap

104.95M

Beta (5Y Monthly)

$ 1.46

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	08-13-2021	06-30-2021	10-Q
13	05-14-2021	03-31-2021	10-Q
14	03-03-2021	12-31-2020	10-K
15	11-13-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

PMV Pharma Q1 EPS $(0.30) Beats $(0.37) Es...
05/09/2024 12:52:45

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by...

Jefferies Initiates Coverage On PMV Pharma...
04/12/2024 13:22:03

Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target o...

PMV Pharmaceuticals Doses First Patient In...
03/27/2024 12:10:37

PMV Pharmaceuticals PYNNACLE Phase I Data ...
03/18/2024 20:02:36

Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated pat...

HC Wainwright & Co. Reiterates Buy on PMV ...
03/07/2024 12:11:00

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

PMV Pharmaceuticals FY23 EPS $(1.44) Vs $(...
02/29/2024 21:19:27

Fiscal Year 2023 Financial ResultsAs of December 31, 2023, PMV Pharma had $228.6 million in cash, cash equivalents, and marketa...

PMV Pharmaceuticals Plans Workforce Reduct...
01/18/2024 21:03:18

Unaudited cash, cash equivalents, and marketable securities totaling approximately $229 million as of December 31, 2023, combin...

PMV Pharmaceuticals Promoted Michael Carul...
01/05/2024 21:03:32

Ladenburg Thalmann Initiates Coverage On P...
12/27/2023 12:02:59

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Pri...

Recap: PMV Pharma Q3 Earnings
11/09/2023 13:50:12

PMV Pharma Q3 EPS $(0.34) Beats $(0.45) Es...
11/09/2023 13:12:30

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by...

HC Wainwright & Co. Maintains Buy on PMV P...
10/16/2023 10:25:59

HC Wainwright & Co. analyst Robert Burns maintains PMV Pharma (NASDAQ:PMVP) with a Buy and lowers the price target from ...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
10/13/2023 17:31:10

why-belden-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Belden Shares Are Trading Lower By Ove...
10/13/2023 17:14:35

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing o...

precision-oncology-pmv-pharmaceuticals-reveals-early-data-from-cancer-study-in-pretreated-patients

Precision Oncology PMV Pharmaceuticals Rev...
10/12/2023 18:13:58

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed ...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
10/12/2023 17:37:47

PMV Pharmaceuticals Shares Resume Trade
10/12/2023 16:39:43

PMV Pharmaceuticals Shares Halted On Circu...
10/12/2023 16:35:35

PMV Pharmaceuticals Updated PC14586 Phase ...
10/12/2023 16:32:24

Updated PC14586 Phase 1 data presented today as a late-breaking poster at 2023 AACR-NCI-EORTC International Conference on Molec...

PMV Pharmaceuticals To Present Updated Pha...
10/11/2023 16:05:17

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecul...